Between Two Benches: From corporate to entrepreneur and back…

Add this event to your calendar:
02/02/2016 12:30 02/02/2016 14:00 America/Los_Angeles Between Two Benches: From corporate to entrepreneur and back… JLABS @ SSF , 329 Oyster Point Blvd , South San Francisco , CA JLABS Bay Area false DD/MM/YYYY

Between Two Benches: From corporate to entrepreneur and back…

JLABS @ SSF , 329 Oyster Point Blvd , South San Francisco , CA

February 02, 2016 from 12:30 PM to 14:00 PM (PST)

$10 - $35

Healthcare entrepreneurs start companies to create solutions that ultimately benefit patients; but this is a long journey, with few road signs along the way. Join us on February 2 to hear insights and lessons learned from a successful co-founder and CMO of one of the first JLABS @ 953 "graduates", Assembly Biosciences.

Uri Lopatin, co-founder, Chief Medical Officer, and Vice President of R&D at Assembly Biosciences (ASMB) will be interviewed by Jeff Calcagno of Johnson & Johnson Innovation. The conversation will focus on the making of a healthcare entrepreneur, how he navigated his way from academia to big biotech to start up, and how he and his teammates-with help from Johnson & Johnson Innovation-led Assembly Biosciences from seed stage to public company in less than two years. The pair will be look at the highlights of Uri's journey, including early mistakes and successes, surprises, lessons learned from working with investors and with Johnson & Johnson Innovation, and more.

Don't miss the opportunity to learn from this lively and candid discussion between two individuals who are making a difference in the biotech space.

The Inspiring Leader Series provides an intimate forum for biotech veterans and experts to share their career successes and challenges. Each accomplished speaker shares lessons learned over the course of his or her professional adventure. The audience is comprised largely of entrepreneurs getting ready to embark on his or her own company-building journey. The series is an interactive and inspiring experience.

11:30am | Registration Opens, Lunch and Networking
12:00pm | Presentation, Interview and Q&A
1:00pm | Program Close

Uri Lopatin | Co-founder, Chief Medical Officer & Vice President of R&D, Assembly Biosciences read bio»
[interviewer] Jeff Calcagno | New Ventures, Johnson & Johnson Innovation read bio»

$25 | General Public
$15 | Academic/Student Rate
$35 | At the door

329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It

Speakers' biographies:

Uri Lopatin Uri Lopatin, M.D. | Co-founder, Chief Medical Officer & Vice President of R&D, Assembly Biosciences
Dr. Lopatin is a co-founder and the Chief Medical Officer and VP R&D for Assembly Pharmaceuticals, Inc. Prior to Assembly, he was a Senior Director for Clinical and Translational Research-Liver Disease at Gilead Sciences, a Translational Medical Leader at Roche, and an Associate Director at Schering Plough. He has designed and coordinated pre-clinical and clinical collaborations, as well as phase I through IV clinical studies of multiple new molecular entities. Dr. Lopatin has published extensively, especially on hepatitis B and immunology and is an author of multiple patents in the field of treatment and diagnosis for viral hepatitis. Dr. Lopatin received his infectious disease Board certification following fellowship training in ID at the NIH, and internal medicine board certification following completion of residency at NYU. He received his MD in 2000 from University of Medicine and Dentistry-New Jersey Medical School, where he was the recipient of the Stanley S Bergen medal of excellence. He holds a BA in biology from Cornell University, where he graduated cum laude with distinction in all subjects.
Connect with Uri: Connect on LinkedIn Follow on Twitter

Jeff Calcagno Jeff Calcagno, M.D. | New Ventures, Johnson & Johnson Innovation
Jeff is a senior operating and business development executive focused on healthcare innovation. He is based in Johnson & Johnson's California Innovation Center, which he helped to establish. He is a member of the New Ventures team, which is responsible for identifying promising new technologies for Johnson & Johnson (J&J), the world's largest healthcare company, and for structuring optimal business relationships. Jeff's career has spanned healthcare and business for over two decades and has included roles as a management consulting at McKinsey & Company and as a research analyst at JP Morgan H&Q. A former entrepreneur who has raised over $50MM in venture money, he ran corporate development for WIDCOMM, a technology company acquired by Broadcom, and served as CFO & CBO for Vela Pharmaceuticals, a venture-backed drug development company. From 2006 to 2010 he was a Principal & Kauffman Fellow at Scale Venture Partners, a venture fund with over $1B under management. Jeff graduated Phi Beta Kappa in Biology from Harvard College and earned an M.D. from Harvard Medical School. He completed his psychiatry residency at UCLA's Neuropsychiatric Institute and was chosen as program chief resident. Afterwards, he was awarded and completed a clinical neuropharmacology fellowship focusing on the care of treatment-refractory patients. A former Rotary International Ambassadorial Scholar, Jeff is conversational in six languages.
Connect with Jeff: Connect on LinkedIn Follow on Twitter

JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit or follow @JNJInnovation.

Event contact

Related content